Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Helicobacter pylori infection

A T Axon1

  • 1Gastroenterology Unit, General Infirmary, Leeds, UK.

The Journal of Antimicrobial Chemotherapy
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Helicobacter pylori (H. pylori) is the primary cause of chronic gastritis and ulcers. Eradicating H. pylori with antibiotics resolves inflammation and prevents ulcer recurrence, marking a significant advance in gastroduodenal pathology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Gut·2016
Same author

Quality assurance and credentialing in endoscopy: the standard of care for the future?

Endoscopy·2009
Same author

Legal and Ethical Considerations: Group 4 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003.

Endoscopy·2004
Same author

Recommendations of the ESGE workshop on Ethics in Teaching and Learning Endoscopy. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003.

Endoscopy·2003
Same author

ESGE/ESGENA Guideline for Live Demonstration Courses.

Endoscopy·2003
Same author

Setting up a quality assurance program in endoscopy.

Endoscopy·2003
Same journal

Improved molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae in a reference laboratory setting.

The Journal of antimicrobial chemotherapy·2026
Same journal

β-lactam susceptibility testing of ampicillin-susceptible non-faecalis enterococcal clinical isolates in France.

The Journal of antimicrobial chemotherapy·2026
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pathology

Background:

  • Helicobacter pylori (H. pylori) discovery is a major advancement in gastroduodenal pathology.
  • H. pylori is the leading cause of chronic gastritis, duodenal ulcers, and likely gastric ulcers.
  • Emerging evidence links H. pylori to gastric cancer pathogenesis.

Purpose of the Study:

  • To review the significance of Helicobacter pylori in gastroduodenal diseases.
  • To discuss the transmission, prevalence, and eradication of H. pylori infections.
  • To highlight the impact of H. pylori eradication on clinical outcomes.

Main Methods:

  • Literature review of studies on Helicobacter pylori.
  • Analysis of epidemiological data on H. pylori prevalence.

Related Experiment Videos

  • Evaluation of treatment outcomes for H. pylori eradication.

    • Main Results:

    • H. pylori is identified as the principal etiological factor for major gastroduodenal conditions.
    • Infection prevalence correlates with age, socioeconomic status, and geographic location.
    • Antibiotic eradication therapy leads to resolution of inflammation and ulcer healing without recurrence.

    Conclusions:

    • H. pylori eradication is crucial for managing chronic gastritis and peptic ulcers.
    • Successful treatment halts disease progression and recurrence.
    • Further research is warranted on H. pylori's role in gastric cancer.